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Treatments
Vasoplegic Syndrome
Monica Arcé BSN-RN, CCRN
Introduction
What is Vasoplegic
Syndrome?
Signs and Symptoms
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Why does it matter?
• Cardiopulmonary Bypass
• Blood transfusion
• Organ transplantation
• Sepsis
• Shock States
• Extended OR cases
(Liu, Yu, Yang, & Green, 2017)
• Vasoplegic syndrome is a loss of 
vasomotor tone and a medical emergency 
(Shaefi, et al., 2018)
• It causes severe hypotension and 
hypoperfusion to vital organs (Abou-Arab, 
et al., 2018)
• Generally seen in post cardiac surgery 
patients or during shock (Shaefi, et al., 
2018)
• Requires very high dose pressors and 
inotropic support 
• May be non-response to medications or 
fluids and require further escalation of 
care 
• Understanding the risk factors along with 
the signs and symptoms of vasoplegic 
syndrome is of upmost importance to 
APNs
• Nurses play a vital role in identifying 
hypotension unresponsive to 
interventions
• Severe hypotension is a medical 
emergency and nurses at the bedside 
should be prepared to take further 
interventions to maintain tissue 
oxygenation such as fluids, oxygen, 
ventilatory support, and vasoactive 
medications
• Identification of possible high risk 
patients by CRNA’s in pre-op and post-op 
should have close observation and 
constant blood pressure monitoring
• Nursing should be prepared for end of life 
discussions and care, should 
interventions not succeed 
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Picture 2. Visual representation of the 
pathophysiology involved in vasoplegic syndrome
(Omar, Zedan, & Nugent, 2015)
Implication for 
Nursing Care
Risk Factors
• Significant arterial hypotension
• MAP <50
• Without clear identifiable cause
• Refractory to traditional treatment
• Normal or high cardiac output
• Low systemic vascular resistance
• Unresponsive to fluid therapy
• Unresponsive to catecholamine treatment
(Liu, Yu, Yang, & Green, 2017)
Conclusion
• Contact with the CPB circuit immediately absorbs 
plasma proteins into the biomembranes and 
directly activates the kinin, complement, and 
clotting pathways
• The kinin pathway produces bradykinin and 
kallikren which lead to neutrophil activation
• Both the intrinsic and extrinsic clotting cascades 
produce thrombin which results in fibrin deposits
• Thrombin goes on to activate platelets which 
adhere to other platelets, neutrophils, and 
exposed basement membranes
• The complement pathway leads to formation of 
C5a which further activates neutrophils
• These neutrophils when activated release 
enzymes and reactive oxygen species (ROS) that 
adhere to membrane surfaces and to endothelial 
surfaces
• “Multiple factors, including thrombin, C5a, and 
cytokines, activate endothelial cells that produce 
vasoactive substances, including nitric oxide (NO) 
and prostacyclin, and express surface receptors.” 
(Omar, Zedan, & Nugent, 2015)
• Following  the acute responses to CPB the 
inflammatory response is exacerbated by 
reinfusion of the blood lost during surgery
Significance of 
Pathophysiology• The reinfused blood contains hemolyzed 
erythrocytes and macroaggregates such as 
denatured proteins, fat globules and platelet and 
leukocyte aggregates
• These fragments clog small capillaries further 
stimulating inflammation
• Additionally, reprofusion syndrome of the heart 
and lungs causes neutrophil adherence and  
further ROS release which causes direct protein, 
lipid, and nucleic acid damage
• This increases capillary permeability causes 
interstitial edema and reduced intravascular 
volume
• All leading to decreased volume and increasing NO 
levels further dilating arterial smooth muscle
• An efflux of potassium through ATP sensitive 
channels results in hyperpolarization of the cell 
causing inactivation of voltage gated calcium 
channels which causes further vasodilation and 
vascular disfunction
• NO then causes dephosphorylation of the myosin  
light chain by increasing production of cyclic GMP 
which prevents muscle contraction by limiting 
actin and myosin interaction
(Omar, Zedan, & Nugent, 2015)
• As  a CVICU nurse vasoplegia is frequently 
seen in patients undergoing 
cardiopulmonary bypass (CPB) or in long 
OR cases
• Vasoplegia is difficult to manage and 
requires excellent nursing and physician 
knowledge and attention
• Vasoplegia has a high mortality rate and is 
not well known
• It is common in most shock states in 
intensive care patients
• CRNAs will experience vasoplegia and need 
to be familiar with it both in post-op 
patients and some shock state emergencies
• Severe, persistent, refractory hypotension 
has a high morbidity and mortality 
(Lambden, Creagh-Brown, Hunt, 
Summers, & Forni, 2018)
• Multifactorial and difficult to manage
• “Vasoplegic syndrome has been 
attributed to a combination of endothelial 
injury, arginine-vasopressin system 
dysfunction, release of other vasodilatory 
inflammatory mediators, and a muscle 
hyperpolarization.” (Sharawy, 2014)
• Without appropriate systemic vascular 
resistance even a high cardiac output has 
no where to go
• Leads to hypoperfusion of organ and 
organ systems which in turn leads to end 
organ failures (Abou-Arab, et al., 2018)
• Understanding the pathophysiology of 
vasoplegia is of vital importance to 
promptly treat the cause and maintain 
adequate oxygenation to tissues
Underlying Pathophysiology
• Vasopressors (high dose)
• Norepinephrine 
• Vasopressin
• Phenylephrine
• Methylene Blue
• β1 blockade
• α2 agonist
• Glucocorticoids
• Blood Products
• Isotonic Fluids
(Levy, et al., 2018)
(Shaefi, et al., 2018)
Picture 1. Cardiovascular system
(Consultants, 2017)
Presentation of Process
• Understanding factors that lead to 
vasoplegia can help prevent and 
treat it
• Multiple factors play a role in loss 
of vasomotor tone all of which 
lead to low organ perfusion
• Refractive to normal hypotensive 
treatments such as fluid and 
catecholamines
• Goals of therapy include: restoring 
MAP, maintaining adequate 
cardiac output, and restoring 
tissue perfusion (Sharawy, 2014)
• Prevention, assessment, and early
treatment are all of great
importance to decrease morbidity 
and mortality
Picture 3. Methane Blue 
used to inhibit NO synthesis
("Singin' the blues: What can 
you do with methylene blue?")
